F972-0260 Screening compound: N-(4-{2-[5-(4-benzylpiperidine-1-carbonyl)-1H-1,3-benzodiazol-2-yl]ethyl}phenyl)acetamide

F972-0260 Screening compound: N-(4-{2-[5-(4-benzylpiperidine-1-carbonyl)-1H-1,3-benzodiazol-2-yl]ethyl}phenyl)acetamide
F972-0260 Screening compound: N-(4-{2-[5-(4-benzylpiperidine-1-carbonyl)-1H-1,3-benzodiazol-2-yl]ethyl}phenyl)acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound F972-0260
N-(4-{2-[5-(4-benzylpiperidine-1-carbonyl)-1H-1,3-benzodiazol-2-yl]ethyl}phenyl)acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F972-0260

Molecular Formula

C30H32N4O2 (C30 H32 N4 O2)

Compound Name

N-(4-{2-[5-(4-benzylpiperidine-1-carbonyl)-1H-1,3-benzodiazol-2-yl]ethyl}phenyl)acetamide

IUPAC name

N-(4-{2-[5-(4-benzylpiperidine-1-carbonyl)-1H-13-benzodiazol-2-yl]ethyl}phenyl)acetamide

SMILES

CC(Nc1ccc(CCc2nc(cc(cc3)C(N4CCC(Cc5ccccc5)CC4)=O)c3[nH]2)cc1)=O

InChI

InChI=1S/C30H32N4O2/c1-21(35)31-26-11-7-22(8-12-26)9-14-29-32-27-13-10-25(20-28(27)33-29)30(36)34-17-15-24(16-18-34)19-23-5-3-2-4-6-23/h2-8,10-13,20,24H,9,14-19H2,1H3,(H,31,35)(H,32,33)

InChI Key

FXXFVRLFARSXEE-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27643479

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

480.61

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

5.130

Distribution Coefficient, logD

5.105

Water Solubility, LogSw

-5.19

Polar Surface Area

59.887

Acid Dissociation Constant (pKa)

10.80

Base Dissociation Constant (pKb)

6.16

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

30.00

F972-0260 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

PI3K-Targeted Library (17255 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

Epigenetics Focused Set (26518 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
Targets:
  • Kinases
  • Proteases

References: we are preparing a list of scientific research reports with F972-0260 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F972-0260?
Check Price and Availability of F972-0260, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F972-0260 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F972-0260
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F972-0260
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F972-0260 available by request